Arkolith/Insider Trading/VRCA/Form 4

Edelman Joseph

10% OwnerVerrica Pharmaceuticals Inc. (VRCA) · full profile →Form 4 · filed Dec 29, 2023
Net Buying
Open-Market Buys
$2.3M
Open-Market Sells
$0
Net Open-Market Flow
$2.3M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 29, 2023Buy(P)116K$7.24$838K7.1M
Dec 28, 2023Buy(P)126K$7.08$893K7.0M
Dec 27, 2023Buy(P)80K$7.20$574K6.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-23-023292) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML